The ABCB1/ABCG2 efflux system at the BBB poses a significant problem for successful drug delivery to the brain, as it hinders the uptake of anti-cancer drugs into the brain and severely limits their efficacy in treating primary and metastatic brain tumors (Schulz et al., 2023). The gene discussed is ABCG2; the disease is cancer.